Please login to the form below

Not currently logged in
Email:
Password:

Recipharm appoints new sales director

Amine Tahiri joins the CMO’s development services sales team

Contract development and manufacturing organisation Recipharm has appointed Amine Tahiri as its new sales director for France.

Tahiri has more than 16 years experience working in the pharma industry, and most recently was commercial manager at Recipharm Fontaine S.A.S. 

He has also held managerial positions at Bristol-Myers Squibb, Laboratories Fournier and Solvay Pharmaceuticals. 

This appointment forms part of Recipharm's strategy to increase the volume of its business and revenues in key European markets.

Commenting on the new appointment, Torkel Gren, senior sales director, development services at Recipharm, said: “I am very happy to welcome such a talent in the sales organisation. 

“Amine will help in to increase our development business in France. We are looking forward to building new relationships with French companies in need of qualified pharmaceutical product development services.

29th June 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...